Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351
收藏数据链接：
官方服务：
资源简介：
Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351
应用场景：
创建时间：
2021-06-17
相关数据集
Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5
To evaluate neutralizing antibody titers against the reference WA1/2020 isolate of SARS-CoV-2 along with omicron subvariants BA.1, BA.2, BA.2.12.1, and BA.4 or BA.5 in vaccinated /boosted and infected
Immunology Database and Analysis Portal2025-10-30 更新60
Table_3_In Silico Analysis Predicts a Limited Impact of SARS-CoV-2 Variants on CD8 T Cell Recognition.xlsx
Since the start of the COVID-19 pandemic, mutations have led to the emergence of new SARS-CoV-2 variants, and some of these have become prominent or dominant variants of concern. This natural course o
NIAID Data Ecosystem50
Table_1_Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody.pdf
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic of novel coronavirus disease (COVID-19). Though vaccines and neutralizing monoclonal antibodies (mAbs) hav
NIAID Data Ecosystem40
Omicron BA.2 (B.1.1.529.2): High Potential for Becoming the Next Dominant Variant
The Omicron variant has three subvariants: BA.1 (B.1.1.529.1), BA.2 (B.1.1.529.2), and BA.3 (B.1.1.529.3). BA.2 is found to be able to alarmingly reinfect patients originally infected by Omicron BA.1.
NIAID Data Ecosystem60
Replication Data for: Assessing the impact of SARS-CoV-2 spike mutations on antibody binding: comparative assessment of Wuhan and JN.1 variants’ full-length spikes in a multiplex Luminex assay
This is a replication dataset for the manuscript titled: "Assessing the impact of SARS-CoV-2 spike mutations on antibody binding: comparative assessment of Wuhan and JN.1 variants’ full-length spikes
NIAID Data Ecosystem40
